Roselabs Finance Stock Screener | Share Price & Fundamental Analysis
ROSELABS
Other Financial Services
Screen Roselabs Finance share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹21.10
▲
0.10 (0.48%)
Market Cap
₹21.90 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
-4.53
EPS (TTM)
₹-0.29
Dividend Yield
-
Debt to Equity
-
52W High
₹36.00
52W Low
₹20.58
Operating Margin
-1.00%
Profit Margin
-
Revenue (TTM)
₹1.00
EBITDA
-
Net Income
-
Total Assets
-
Total Equity
₹-5.00
Roselabs Finance Share Price History - Stock Screener Chart
Screen ROSELABS historical share price movements with interactive charts. Analyze price trends and patterns.
Roselabs Finance Company Profile - Fundamental Screener
Screen Roselabs Finance company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ROSELABS shares.
Sector
Financial Services
Industry
Other Financial Services
Sub-Sector
Other Financial Services
Segment
E
ISIN
INE475C01012
Roselabs Finance Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ROSELABS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 7 | 29 | 23 |
| Current Assets | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 17 | 18 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 7 | 29 | 23 |
| Current Liabilities | 5 | 5 | 4 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | -5 | -4 | -4 | -6 | -6 | -3 | -3 | -3 | -3 | -1 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | -15 | -14 | -14 | -16 | -16 | -13 | -13 | -13 | -13 | -11 |
Screen ROSELABS income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March | 2011-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 4 | 2 | 8 | 14 | 0 |
| Expenses | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 3 | 2 | 8 | 10 | 0 |
| EBITDA | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 4 | 0 |
| Operating Profit % | -1.00% | -44.00% | -15.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.00% | 21.00% | 4.00% | 29.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 3 | 4 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 2 | 0 | -3 | 0 | 0 | -1 | -1 | -2 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 2 | 0 | -3 | 0 | 0 | 0 | -1 | -2 | 1 | 0 |
| EPS | -0.30 | -0.29 | -0.13 | 2.02 | -0.44 | -2.57 | -0.14 | -0.39 | -0.43 | -1.43 | -2.40 | 0.49 | 0.05 |
Roselabs Finance Cash Flow Screener - Liquidity Fundamentals
Screen ROSELABS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 1 | 0 | 0 | 0 | -1 | 23 | -6 | 7 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 0 | -1 | 0 | 0 | 0 | 0 | -24 | 6 | -7 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
Screen ROSELABS shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 74.25% | 74.25% | 74.25% | 74.25% | 74.25% | 74.25% | 74.25% | 74.25% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.15% | 15.15% | 15.14% | 15.17% | 15.17% | 15.12% | 15.13% | 14.95% |
| Other Holding | 10.60% | 10.61% | 10.61% | 10.58% | 10.58% | 10.63% | 10.62% | 10.80% |
| Shareholder Count | 1,389 | 1,415 | 1,427 | 1,324 | 1,313 | 1,350 | 1,397 | 1,269 |
Roselabs Finance Dividend Screener - Share Yield Analysis
Screen ROSELABS dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Roselabs Finance Index Membership - Market Screener Classification
Screen ROSELABS by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Roselabs Finance Market Events Screener - Corporate Actions
Screen ROSELABS market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -11.47% | ||
| Annual General Meeting | NA | -1.63% | ||
| 2025-10-17 | 2025-10-17 | Quarterly Result Announcement | NA | 2.07% |
| 2025-07-18 | 2025-07-18 | Quarterly Result Announcement | NA | -7.12% |
| 2025-04-18 | 2025-04-18 | Quarterly Result Announcement | NA | -5.88% |
| 2025-01-17 | 2025-01-17 | Quarterly Result Announcement | NA | 1.54% |
| 2024-10-18 | 2024-10-18 | Quarterly Result Announcement | NA | 3.46% |
| 2018-08-08 | 2018-08-08 | Change Of Name | NA | 0.00% |
Roselabs Finance Competitors Screener - Peer Comparison
Screen ROSELABS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Spice Lounge Food Works | 3,660 | 524.00 | 106 | % | 6 | 50.10 |
| Algoquant Fintech | 1,686 | 102.19 | 235 | 49.78% | 32 | 46.68 |
| LKP Finance | 1,318 | 717.42 | 14 | -84.02% | 2 | 44.16 |
| Wealth First Portfolio Managers | 1,055 | 31.17 | 60 | -10.30% | 34 | 38.43 |
| Prime Securities | 951 | 28.38 | 89 | 34.23% | 39 | 44.30 |
| RNFI Services | 811 | 41.52 | 923 | -2.09% | 20 | 38.93 |
| Arunis Abode | 769 | 51.68 | 1 | -70.59% | 0 | 72.96 |
| Investment Trust of India | 600 | 20.60 | 365 | 19.40% | 46 | 31.17 |
| Delphi World Money | 401 | 206.50 | 24 | -99.74% | -2 | 60.84 |
| NDL Ventures | 297 | 1,152 | 14.25% | 2 | 43.25 |
Roselabs Finance Company Announcements - News Screener
Screen ROSELABS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-10-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-17 | Unaudited Financial Results Along With Limited Review Report For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-17 | Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-10 | Board Meeting Intimation for Consideration And Approval Of The Un-Audited Financial Results Alongwith Limited Review Report Of The Company For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-08-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-28 | Reg. 34 (1) Annual Report. | View |
| 2025-08-28 | Notice Of 31St Annual General Meeting Of Roselabs Finance Limited Is Enclosed Herewith | View |
| 2025-08-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-21 | Intimation Of The 31St Annual General Meeting Of The Company | View |
| 2025-08-11 | Board Meeting Outcome for Update On Scheme Of Merger By Absorption Of The Company National Standard (India) Limited And Sanathnagar Enterprises Limited With Lodha Developers Limited | View |
| 2025-08-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-07-21 | Unaudited Financial Results Along With Limited Review Report For The Quarter Ended June 30 2025 | View |
| 2025-07-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-07-18 | Intimation Of 31St Annual General Meeting Of The Company | View |
| 2025-07-18 | Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30 2025 | View |
| 2025-07-14 | Board Meeting Intimation for Consideration And Approval Of The Un-Audited Financial Results Alongwith Limited Review Report Of The Company For The Quarter Ended June 30 2025. | View |